Login to Your Account



Captisol is the Key

Ligand Views $36.3M CyDex Acquisition as 'Game Changer'

By Tom Wall


Friday, January 28, 2011
Although its $36.3-million acquisition of privately held CyDex Pharmaceuticals Inc., of Lenexa, Kan., is the fourth in the last 28 months for Ligand Pharmaceuticals Inc., CEO John Higgins described it as "transformational" and a "game changer."

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription